These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3691627)

  • 1. Impairment of immunogenicity by antigen presentation in liposomes made from dimyristoylphosphatidylethanolamine linked to the secretion of prostaglandins by macrophages.
    Bakouche Q; David F; Gerlier D
    Eur J Immunol; 1987 Dec; 17(12):1839-42. PubMed ID: 3691627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.
    Bakouche O; Gerlier D
    Immunology; 1986 Feb; 57(2):219-23. PubMed ID: 3949369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.
    Bakouche O; Gerlier D
    Immunology; 1986 Jul; 58(3):507-13. PubMed ID: 3733150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cellular immune response to measles viral glycoproteins: role of the antigen vector.
    Bakouche O; Mougin B; Gerlier D
    Immunology; 1987 Dec; 62(4):605-11. PubMed ID: 3428926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antibody response to liposome-associated Gross-virus cell-surface antigen (GCSAa).
    Gerlier D; Sakai F; Doré JF
    Br J Cancer; 1980 Feb; 41(2):236-42. PubMed ID: 7370163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of gross virus-associated cell-surface antigen with liposomes.
    Sakai F; Gerlier D; Doré JF
    Br J Cancer; 1980 Feb; 41(2):227-35. PubMed ID: 7370162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes as immune adjuvants: T cell dependence.
    Beatty JD; Beatty BG; Paraskevas F; Froese E
    Surgery; 1984 Aug; 96(2):345-51. PubMed ID: 6611598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
    Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
    Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
    Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
    J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liposomal model membrane composition on immunogenicity.
    Dancey GF; Yasuda T; Kinsky SC
    J Immunol; 1978 Apr; 120(4):1109-13. PubMed ID: 641340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.
    Harding CV; Collins DS; Kanagawa O; Unanue ER
    J Immunol; 1991 Nov; 147(9):2860-3. PubMed ID: 1918996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for direct control of an in vitro plaque-forming cell response by quantitative properties of intact, fluid, haptenated liposomes: a potential model system for antigen presentation by macrophages.
    Humphries GM
    J Immunol; 1981 Feb; 126(2):688-92. PubMed ID: 6161186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors.
    Dal Monte P; Szoka FC
    J Immunol; 1989 Mar; 142(5):1437-43. PubMed ID: 2465339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
    Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
    Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two signals are required for accessory cells to induce B cell unresponsiveness. Tolerogenic Ig and prostaglandin.
    Schad VC; Phipps RP
    J Immunol; 1988 Jul; 141(1):79-84. PubMed ID: 2454266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition.
    Badiee A; Jaafari MR; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):37-44. PubMed ID: 19615870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-dependent and B-cell-dependent proliferative T-cell populations in the peritoneal exudate cells of immunized mice.
    Nitta T; Wakairo Y; Hirayama N; Nakano M
    Kitasato Arch Exp Med; 1991 Apr; 64(1):1-14. PubMed ID: 1798235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.